• Catrina C Crisp, Sindura Bandi, Steven D Kleeman, Susan H Oakley, Christine M Vaccaro, Maria V Estanol, Angela N Fellner, and Rachel N Pauls.
• Division of Urogynecology and Pelvic Reconstructive Surgery, Department of Obstetrics and Gynecology, Good Samaritan Hospital, Cincinnati, OH 45220, USA. Catrina_Crisp@trihealth.com
• Am. J. Obstet. Gynecol. 2012 Nov 1; 207 (5): 433.e1-6.

ObjectiveTo determine whether patient-controlled analgesia or scheduled intravenous analgesia provides superior pain relief and satisfaction with pain control after vaginal reconstructive surgery.Study DesignFifty-nine women scheduled for vaginal reconstructive surgery were enrolled in this randomized trial. Operative procedures and postoperative orders were standardized. Visual analog scales for pain and satisfaction with pain control were recorded during the hospital stay and 2 weeks after surgery.ResultsPatients receiving patient-controlled analgesia had less pain on postoperative day 1, 25 mm vs 39 mm, on visual analog scales (P = .007). Although this group used twice as much hydromorphone (3.57 mg vs 1.48 mg, P < .001), there was no difference in side effects, length of hospital stay, or complications. For the sample overall, larger amounts of narcotic used correlated with higher pain scores (r = 0.364, P = .009) and worse satisfaction scores (r = -0.348, P = .012).ConclusionIn patients undergoing vaginal surgery, patient-controlled analgesia offers superior pain relief on postoperative day 1 when compared with scheduled, nurse-administered hydromorphone.Copyright © 2012 Mosby, Inc. All rights reserved.

25 keywords...

hide…